Firefly Neuroscience, Inc. (AIFF)
NASDAQ: AIFF · Real-Time Price · USD
2.780
+0.100 (3.73%)
At close: Sep 5, 2025, 4:00 PM
2.760
-0.020 (-0.72%)
After-hours: Sep 5, 2025, 7:59 PM EDT
Firefly Neuroscience Revenue
Firefly Neuroscience had revenue of $299.00K in the quarter ending June 30, 2025, with 2,890.00% growth. This brings the company's revenue in the last twelve months to $428.00K, up 568.75% year-over-year. In the year 2024, Firefly Neuroscience had annual revenue of $108.00K, down -78.31%.
Revenue (ttm)
$428.00K
Revenue Growth
+568.75%
P/S Ratio
62.42
Revenue / Employee
$32,923
Employees
13
Market Cap
37.23M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 108.00K | -390.00K | -78.31% |
Dec 31, 2023 | 498.00K | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | 32.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAIFF News
- 15 hours ago - Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America - GlobeNewsWire
- 10 days ago - Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR' Platform - GlobeNewsWire
- 7 weeks ago - Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research - GlobeNewsWire
- 2 months ago - Firefly Neuroscience to be Added to the Russell Microcap® Index - GlobeNewsWire
- 2 months ago - Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer's Patients - GlobeNewsWire
- 4 months ago - Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc. - GlobeNewsWire
- 4 months ago - Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc. - GlobeNewsWire
- 6 months ago - Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01 - Newsfile Corp